论文部分内容阅读
目的探究特异性免疫疗法治疗常年性变应性鼻炎(PAR)的临床优势。方法本文主要采用前瞻性研究,共收集80例2009-01～2011-08间,在本院耳鼻喉科就诊的PAR患者,分别进行特异性免疫疗法和传统的翼管神经无水酒精注射疗法治疗,再进行统计学分析比较两组患者的情况。结果 80例患者的变应原主要有尘螨、花粉、真菌等;研究组和对照组的总有效率分别为92.5%和75%,经卡方检验后χ,2=14.6,P<0.05,差异有统计学意义。结论随着对PAR认识的不断加深,特异性免疫疗法对PAR治疗的总有效率较高,因此其应用面将会越来越广,值得在临床上推广应用。
Objective To investigate the clinical advantages of specific immunotherapy in the treatment of perennial allergic rhinitis (PAR). Methods A prospective study was conducted in this study. A total of 80 patients with PAR in our otolaryngology clinic from 2009 to 2011-08 were enrolled in this study. They were treated with specific immunotherapy and traditional pterygium , Then conduct statistical analysis to compare the two groups of patients. Results The total allergens of 80 patients were dust mites, pollen, fungi and so on. The total effective rates of the study group and the control group were 92.5% and 75%, respectively. After chi square test, χ, 2 = 14.6, P < The difference was statistically significant. Conclusion With the deepening of understanding of PAR, the specific immunotherapy of PAR treatment of the total effective rate is high, so its application will be more and more widely, it is worth popularizing the clinical application.